In Vivo Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model
In Vivo · 2025
DOI: 10.21873/invivo.13932 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Chad R Schultz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, U.S.A. Hauptthemen laut MEDLINE: Sulfinic Acids, Neuroblastoma, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, U.S.A.
- Society for Natural Product and Drug Research (GENAWIF), Aachen, Germany.
- Department of Plant Physiology, RWTH Aachen University, Aachen, Germany.
- Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, U.S.A.; bachma26@msu.edu.
Zitieren
APA
Schultz, C. R., Gruhlke, M. C. H., Slusarenko, A. J., & Bachmann, A. S. (2025). In Vivo Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model. In Vivo. https://doi.org/10.21873/invivo.13932
Vancouver
Schultz CR, Gruhlke MCH, Slusarenko AJ, Bachmann AS. In Vivo Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model. In Vivo. 2025. doi:10.21873/invivo.13932
BibTeX
@article{Schultz2025,
author = {Schultz, Chad R and Gruhlke, Martin C H and Slusarenko, Alan J and Bachmann, André S},
title = {In Vivo Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.13932}
}
EUVIMED